Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Positive mobilization margins alone do not influence survival after pancreatico-duodenectomy

Positive mobilization margins alone do not influence survival after pancreatico-duodenectomy, reports the most recent issue of the Annals of Surgery.

News image

fiogf49gjkf04

Dr Nigel Jamieson and colleagues determined the prognostic influence of residual tumor at or within 1 mm of the mobilization margins compared with transection margins following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

The prognostic strength of residual tumor status increases with frequency of margin positivity and is enhanced by protocol driven pathology reporting.

Currently, margins are treated uniformly with tumor at or close to any margin considered of equal prognostic significance.

The resection involved a mobilization phase freeing the posterior margin and anterior surface then a transection phase requiring lympho-vascular division forming the medial resection and pancreatic transection margin.

The comparative assessment of the relative importance of tumor involvement of these different margins has not previously been investigated.

Retrospective analysis of 148 consecutive resections for pancreatic ductal adenocarcinoma from 1996–2007 was performed.

The research team found that the individual margins were separately identified and analyzed by a senior pathologist.

An residual resection was defined as microscopic evidence of tumor 1 mm or less from a resection margin.

Residual tumor status was confirmed in 74% patients
Annals of Surgery

The researchers found that residual tumor at or within 1 mm of the mobilization margins tumor extension included both anterior and posterior cases.

Transection margins included pancreatic neck/body transection, medial and adjacent transection margins.

Residual tumor status was confirmed in 74% patients.

The team noted that the medial and posterior margins were most commonly involved.

Residual tumor status was found to an independent predictor of poor outcome.

Residual tumor at or within 1 mm of the mobilization margins involvement only was associated with a significantly longer median survival of 19 months versus 11 months for those with transection margin tumor involvement.

The research team found no significant difference in the survival of the residual tumor at or within 1 mm of the mobilization margins compared with R0 group.

Dr Jamieson's team concludes, "Following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma, involvement of the transection margins in contrast to mobilization margins defines a group whose outcome is significantly worse."

"This may impact upon the allocation of adjuvant therapy within the setting of randomized controlled trials."

Ann Surgery 2010: 251(6): 1003-1010
31 May 2010

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us